Top Section/Ad
Top Section/Ad
Most recent
Sfr4.9bn trade is largest European ECM deal since National Grid’s £7bn rights issue in 2024
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
More articles/Ad
More articles/Ad
More articles
-
The biggest IPO of the year so far in Europe is multiple times covered, according to sources -
KBRA expects to upgrade deal if merger with Orangetheory goes through
-
US drug maker's stake in Haleon set to fall to 24%
-
Risk appetite is back and more deals coming, though one bad IPO would damage confidence in the recovery
-
More companies are getting ratings to woo bond investors
-
Europe's biggest IPO of the year so far gains traction with investors
